Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Ph, Van Hootegem"'
Autor:
Catherine Reenaers, S. Naegels, T. Moreels, M. Van Outryve, Filip Baert, Geneviève Veereman, Hubert Piessevaux, Harald Peeters, Yves Horsmans, V. Muls, Ph. Van Hootegem, J Holvoet, Fazia Mana, Olivier Dewit, M. De Vos, Jean-Luc Gala
Publikováno v:
Clinical Biochemistry. 44:1062-1066
TPMT deficiency is associated with azathioprine (AZA)-induced myelosuppression (MS). However, in one previous study, only about ¼ of MS episodes in Crohn's Disease patients under AZA can be attributed to TPMT deficiency. Recently, new TPMT mutations
Autor:
S, Vermeire, E, Louis, O, Dewit, D, Franchimont, T, Moreels, M, Ferrante, J-F, Rahier, Ph, Van Hootegem, M, De Vos, F, Mana, F, Baert
Publikováno v:
Acta gastro-enterologica Belgica. 78(1)
Autor:
S, Vanooteghem, J, Arts, S, Decock, P, Pieraerts, W, Meersseman, C, Verslype, Ph, Van Hootegem
Publikováno v:
Acta gastro-enterologica Belgica. 77(3)
Mushroom poisoning by Amanita phalloides is a rare but potentially fatal disease. The initial symptoms of nausea, vomiting, abdominal pain and diarrhea, which are typical for the intoxication, can be interpreted as a common gastro-enteritis. The into
Autor:
G, Verset, I, Borbath, T, Delaunoit, P, Demetter, G, Demolin, A, Hendlisz, P, Pattyn, S, Pauwels, M, Peeters, G, Roeyen, E, Van Cutsem, Ph, Van Hootegem, C, Verslype, J L, Van Laethem
Publikováno v:
Acta gastro-enterologica Belgica. 72(1)
The management of gastro-entero-pancreatic neuroendocrine tumours is evolving thanks to new TNM-classification, diagnostic and staging procedures and new therapeutic options. Targeting new pathways, mostly angiogenesis, development of novel agents is
Autor:
I, Borbath, F, Jamar, T, Delaunoit, P, Demetter, G, Demolin, A, Hendlisz, P, Pattyn, M, Peeters, G, Roeyen, E, Van Cutsem, Ph, Van Hootegem, J L, Van Laethem, C, Verslype, S, Pauwels
Publikováno v:
Acta gastro-enterologica Belgica. 72(1)
Gastro-entero-pancreatic neuroendocrine tumours (GEP NET) represent a rare and highly heterogeneous entity that often is revealed by vague and non-specific symptoms, leading to a delayed diagnosis. Here we will review some of the most regularly obser
Autor:
G, Roeyen, T, Chapelle, I, Borbath, T, Delaunoit, P, Demetter, G, Demolin, A, Hendlisz, P, Pattyn, S, Pauwels, M, Peeters, E, Van Cutsemo, Ph, Van Hootegem, J L, Van Laethem, C, Verslype, D, Ysebaert
Publikováno v:
Acta gastro-enterologica Belgica. 72(1)
Surgery represents the only chance of cure for a patient with a neuroendocrine tumour (NET). The main indications for surgery lie in the risk of developing metastatic disease with increasing tumour diameter and for a functioning NET also in control o
Autor:
I, Dero, M, De Pauw, I, Borbath, T, Delaunoit, P, Demetter, G, Demolin, A, Hendlisz, P, Pattyn, S, Pauwels, G, Roeyen, E, Van Cutsem, Ph, Van Hootegem, J L, Van Laethem, C, Verslype, M, Peeters
Publikováno v:
Acta gastro-enterologica Belgica. 72(1)
Carcinoid heart disease (CHD) develops in serotonin-producing neuroendocrine tumours (NET) due to fibrotic endocardial plaques with associated valve dysfunction leading most often to right-sided heart failure. The classical carcinoid syndrome usually
Autor:
T, Delaunoit, M, Van den Eynde, I, Borbath, P, Demetter, G, Demolin, P, Pattyn, S, Pauwels, M, Peeters, G, Roeyen, E, Van Cutsem, Ph, Van Hootegem, J L, Van Laethem, C, Verslype, A, Hendlisz
Publikováno v:
Acta gastro-enterologica Belgica. 72(1)
Gastroenteropancreatic Neuroendocrine Tumours (GEP NET) are heterogeneous and rare malignancies although their prevalence is increasing. Multiple therapeutic approaches are available to date for their management, including surgery, hormonal and immun
Autor:
C, Verslype, S, Carton, I, Borbath, T, Delaunoit, P, Demetter, G, Demolin, A, Hendlisz, P, Pattyn, S, Pauwels, M, Peeters, G, Roeyen, Ph, Van Hootegem, J L, Van Laethem, E, Van Cutsem
Publikováno v:
Acta gastro-enterologica Belgica. 72(1)
Somatostatin analogs (SSAs) have an important role in the management of patients with neuroendocrine tumours of the gastrointestinal tract and pancreas (GEP NETs). These compounds can control the symptoms induced by the production of hormones and pep
Autor:
A, Hendlisz, P, Flamen, M, Van den Eynde, I, Borbath, P, Demetter, G, Demolin, P, Pattyn, S, Pauwels, M, Peeters, G, Roeyen, E, Van Cutsemo, Ph, Van Hootegem, J L, Van Laethem, C, Verslype, T, Delaunoit
Publikováno v:
Acta gastro-enterologica Belgica. 72(1)
Gastro-entero-pancreatic neuroendocrine tumours (GEP NET) are a heterogeneous group of proliferative disorders whose management dramatically relies on tumour biology. For well-differentiated, low-proliferative index tumours, locoregional treatment an